Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Analyst Coverage
Firm Analyst
Aegis Capital Corp.   Ram Selvaraju
Jefferies LLC   Thomas Wei
Ladenburg Thalmann Securities   Matthew Kaplan
ROTH Capital Partners LLC   Joe Pantginis
Wedbush Securities, Inc.   David Nierengarten

Stemline Therapeutics is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Stemline Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Stemline Therapeutics or its management. Stemline Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Copyright 2015 - Stemline Therapeutics, Inc. All rights reserved